Jagsonpal Pharmaceuticals Ltd.
|
Balance Sheet
|
|
You can view the
Balance Sheet
for the last 5 years.
Market Cap. (Rs.)
|
847.73 Cr.
|
P/BV
|
5.33
|
Book Value (Rs.)
|
60.14
|
52 Week High/Low (Rs.)
|
515/274
|
FV/ML
|
5/1
|
P/E(X)
|
31.73
|
Bookclosure
|
21/08/2023
|
EPS (Rs.)
|
10.11
|
Div Yield (%)
|
1.56
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
No. of Equity Shares (in Lacs) | 261.98 | 261.98 | 261.98 | 261.98 | 261.98 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 13.10 | 13.10 | 13.10 | 13.10 | 13.10 |
Total Share Capital | 13.10 | 13.10 | 13.10 | 13.10 | 13.10 |
| | | | | |
Revaluation Reserves | 0.00 | 7.84 | 7.84 | 7.84 | 7.84 |
Reserves and Surplus | 145.79 | 109.92 | 100.99 | 90.10 | 83.53 |
Total Reserves and Surplus | 145.79 | 117.76 | 108.83 | 97.93 | 91.37 |
Total Shareholders Funds | 158.89 | 130.86 | 121.93 | 111.03 | 104.47 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Deferred Tax Liabilities [Net] | 2.16 | 2.19 | 1.86 | 3.09 | 3.12 |
Other Long Term Liabilities | 5.25 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Provisions | 1.08 | 1.26 | 0.02 | 0.00 | 0.00 |
Total Non-Current Liabilities | 8.49 | 3.44 | 1.88 | 3.09 | 3.12 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Short Term Borrowings | 0.00 | 0.00 | 6.79 | 4.66 | 3.79 |
Trade Payables | 16.36 | 16.29 | 18.05 | 11.71 | 11.86 |
Other Current Liabilities | 10.83 | 17.38 | 14.71 | 16.46 | 12.55 |
Short Term Provisions | 0.38 | 0.49 | 0.85 | 0.00 | 0.00 |
Total Current Liabilities | 27.57 | 34.16 | 40.40 | 32.83 | 28.19 |
| | | | | |
Total Capital And Liabilities | 194.95 | 168.45 | 164.20 | 146.95 | 135.78 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 24.28 | 22.37 | 23.35 | 22.06 | 21.61 |
Intangible Assets | 0.00 | 2.38 | 2.38 | 0.03 | 0.03 |
Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 1.90 | 1.89 |
Intangible Assets Under Development | 0.00 | 0.00 | 0.00 | 2.35 | 2.06 |
Fixed Assets | 24.28 | 24.75 | 25.72 | 26.34 | 25.60 |
Non-Current Investments | 1.12 | 20.58 | 12.06 | 11.39 | 0.00 |
Long Term Loans And Advances | 0.00 | 0.00 | 0.44 | 0.00 | 0.00 |
Other Non-Current Assets | 4.99 | 12.35 | 5.50 | 14.32 | 12.63 |
Total Non-Current Assets | 30.39 | 57.68 | 43.73 | 52.04 | 38.23 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Current Investments | 0.00 | 22.14 | 3.25 | 0.00 | 0.00 |
Inventories | 20.68 | 29.74 | 29.72 | 29.33 | 32.69 |
Trade Receivables | 20.87 | 15.58 | 12.66 | 21.45 | 20.75 |
Cash And Cash Equivalents | 114.63 | 26.15 | 60.23 | 38.07 | 38.53 |
Short Term Loans And Advances | 0.00 | 0.31 | 0.27 | 0.00 | 0.00 |
OtherCurrentAssets | 8.39 | 16.86 | 14.34 | 6.06 | 5.58 |
Total Current Assets | 164.56 | 110.78 | 120.48 | 94.91 | 97.56 |
| | | | | |
Total Assets | 194.95 | 168.45 | 164.20 | 146.95 | 135.78 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 6.09 | 5.87 | 5.99 | 6.06 | 0.69 |
| | | | | |
NON-CURRENT INVESTMENTS | | | | | |
Non-Current Investments Unquoted Book Value | 1.02 | 20.58 | 12.06 | 11.39 | 0.00 |